Zelira Therapeutics' market value is the price at which a share of Zelira Therapeutics trades on a public exchange. It measures the collective expectations of Zelira Therapeutics Limited investors about its performance. Zelira Therapeutics is trading at 0.23 as of the 25th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.23. With this module, you can estimate the performance of a buy and hold strategy of Zelira Therapeutics Limited and determine expected loss or profit from investing in Zelira Therapeutics over a given investment horizon. Check out Zelira Therapeutics Correlation, Zelira Therapeutics Volatility and Zelira Therapeutics Alpha and Beta module to complement your research on Zelira Therapeutics.
Please note, there is a significant difference between Zelira Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zelira Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zelira Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Zelira Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Zelira Therapeutics' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Zelira Therapeutics.
0.00
06/28/2025
No Change 0.00
0.0
In 5 months and 30 days
12/25/2025
0.00
If you would invest 0.00 in Zelira Therapeutics on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Zelira Therapeutics Limited or generate 0.0% return on investment in Zelira Therapeutics over 180 days. Zelira Therapeutics is related to or competes with Sigyn Therapeutics. Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialisation o... More
Zelira Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Zelira Therapeutics' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Zelira Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zelira Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Zelira Therapeutics' standard deviation. In reality, there are many statistical measures that can use Zelira Therapeutics historical prices to predict the future Zelira Therapeutics' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Zelira Therapeutics. Your research has to be compared to or analyzed against Zelira Therapeutics' peers to derive any actionable benefits. When done correctly, Zelira Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Zelira Therapeutics.
Zelira Therapeutics Backtested Returns
Zelira Therapeutics shows Sharpe Ratio of -0.0312, which attests that the company had a -0.0312 % return per unit of risk over the last 3 months. Zelira Therapeutics exposes seventeen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Zelira Therapeutics' Standard Deviation of 3.74, market risk adjusted performance of (1.02), and Mean Deviation of 1.1 to validate the risk estimate we provide. The firm maintains a market beta of 0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Zelira Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Zelira Therapeutics is expected to be smaller as well. At this point, Zelira Therapeutics has a negative expected return of -0.12%. Please make sure to check out Zelira Therapeutics' jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Zelira Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation
0.18
Very weak predictability
Zelira Therapeutics Limited has very weak predictability. Overlapping area represents the amount of predictability between Zelira Therapeutics time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Zelira Therapeutics price movement. The serial correlation of 0.18 indicates that over 18.0% of current Zelira Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.18
Spearman Rank Test
-0.37
Residual Average
0.0
Price Variance
0.0
Zelira Therapeutics lagged returns against current returns
Autocorrelation, which is Zelira Therapeutics otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Zelira Therapeutics' otc stock expected returns. We can calculate the autocorrelation of Zelira Therapeutics returns to help us make a trade decision. For example, suppose you find that Zelira Therapeutics has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Zelira Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Zelira Therapeutics otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Zelira Therapeutics otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Zelira Therapeutics otc stock over time.
Current vs Lagged Prices
Timeline
Zelira Therapeutics Lagged Returns
When evaluating Zelira Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Zelira Therapeutics otc stock have on its future price. Zelira Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Zelira Therapeutics autocorrelation shows the relationship between Zelira Therapeutics otc stock current value and its past values and can show if there is a momentum factor associated with investing in Zelira Therapeutics Limited.
Other Information on Investing in Zelira OTC Stock
Zelira Therapeutics financial ratios help investors to determine whether Zelira OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zelira with respect to the benefits of owning Zelira Therapeutics security.